CavoGene LifeSciences Competitors and Similar CompaniesClear all
CavoGene LifeSciences's competitors and similar companies include moksha8 Pharmaceuticals, Cell Therapies, Ambrx and Precigen.
 CavoGene LifeSciences CavoGene LifeSciences is a biotechnology company focused on the treatment of neurodegenerative diseases.
|  moksha8 Pharmaceuticals Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders. |  Cell Therapies Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products. |  Ambrx Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code. |  Precigen Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases. | |
Founding Date | Founding Date 2018 | Founding Date 2006 | Founding Date 2003 | Founding Date 2003 | Founding Date 1998 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Cleveland, US HQ Glen Burnie, US | Locations Berwyn, US HQ Ciudad De México, MX | Locations Melbourne, AU HQ | Locations San Diego, US HQ | Locations Germantown, US HQ Gent, BE Sioux Center, US |
Employees | Employees 1 | Employees 370 | Employees 733% decrease | Employees 70 | Employees 601 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 1.8 b | Valuation ($) 246.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $7.4m (FY, 2022) | Revenue (est.) $9.7m (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($78m) (FY, 2022) | Net income ($250.6m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 224.1m | Total funding raised N/A | Total funding raised $ 347.9m | Total funding raised $ 379m |
For sources of this data, please see the company profile
View Company Profiles
moksha8 Pharmaceuticals
HQ
Berwyn, US
Employees
370
Moksha8 is a pharmaceutical company which provides therapeutics for the treatment of central nervous system and mental health disorders.
View companyCell Therapies
HQ
Melbourne, AU
Employees
73↓ 3% decrease
Cell Therapies is a manufacturer of cell therapies, gene therapies, cellular immunotherapies, and regenerative medicine products.
View companyAmbrx
HQ
San Diego, US
Employees
70
Ambrx is a biopharmaceutical company that discovers and develops engineered precision biologics therapeutics using an expanded genetic code.
View companyPrecigen
HQ
Germantown, US
Employees
601
Precigen (formerly known as Intrexon) is a biopharmaceutical company developing gene and cellular therapies for immuno-oncology, autoimmune, and infectious diseases.
View company